The cost of Methocarbamol 500mg can vary significantly depending on factors such as the pharmacy, insurance coverage, and whether a generic or brand-name product is purchased.
What is the typical price range for Methocarbamol 500mg?
Without insurance, a 30-day supply of Methocarbamol 500mg tablets can range from approximately $20 to $60 or more [1]. Prices may be lower for generic versions compared to brand-name formulations. Coupon programs or discount cards can often reduce out-of-pocket expenses.
How does insurance affect the cost of Methocarbamol 500mg?
Insurance plans can considerably lower the cost of Methocarbamol 500mg, often reducing it to a co-payment of a few dollars to around $20, depending on the specific plan's formulary and co-payment structure [1]. It is advisable to check with your insurance provider for specific coverage details and pricing.
Are there different versions of Methocarbamol 500mg that affect cost?
Methocarbamol is available in both generic and brand-name forms. Generic medications are typically less expensive than their brand-name counterparts due to lower manufacturing and marketing costs [1].
Where can I find discount options for Methocarbamol 500mg?
Discount cards and coupons are frequently available from various sources and can be used at many pharmacies to lower the price of Methocarbamol 500mg [1]. Online pharmacies and prescription discount websites may also offer competitive pricing.
What is the patent status for Methocarbamol?
Methocarbamol is an older drug, and its original patents have long expired. This means that generic versions have been available for many years, contributing to its affordability [2]. Information on drug patent expirations can be found at DrugPatentWatch.com [3].
Sources:
1. GoodRx. (n.d.). Methocarbamol Prices, Coupons, and Patient Assistance Programs. Retrieved from https://www.goodrx.com/methocarbamol
2. U.S. Food & Drug Administration. (n.d.). Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book). Retrieved from https://www.accessdata.fda.gov/scripts/cder/ob/
3. DrugPatentWatch.com. (n.d.). Retrieved from https://www.drugpatentwatch.com/